Nishino Tomofumi, Hyodo Kojiro, Matsumoto Yukei, Yanagisawa Yohei, Yamazaki Masashi
Department of Orthopaedic Surgery, Institute of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba 305-8575, Ibaraki, Japan.
J Clin Med. 2024 Feb 10;13(4):1027. doi: 10.3390/jcm13041027.
Glucocorticoids induce osteoporosis, while bisphosphonates treat it, yet both can lead to atypical femoral fractures. Patients on both agents may face challenges in healing from such fractures due to their pathophysiology and pharmacological effects.
Intramedullary nail surgery was performed on 20 limbs in 19 patients with atypical femoral fractures and autoimmune diseases, who had received bisphosphonates for GC-induced osteoporosis. The average durations of glucocorticoid and bisphosphonate use were 17 and 9 years (standard deviation: 7.59 and 4.35), respectively, and the mean follow-up period was 66 months. Fifteen and five limbs were fractured at the subtrochanter and diaphysis, respectively. The surgical techniques (type of nail) and additional procedures performed in these cases were examined. The post-operative alignment and reduction status on radiographs were examined to determine their relationship with post-operative outcomes.
Cephalomedullary long nails were inserted in nine limbs and antegrade intramedullary nails in 11 limbs. As an additional surgical procedure, open reduction, bone grafting and drilling were carried out on six, two, and five limbs, respectively. Regarding malalignment on radiographs, AP images showed varus in four limbs, and lateral images showed extension in two limbs. Regarding the cortical discontinuity, the distal fragment of the 11th limb shifted posteriorly in the lateral view. Gaps at the fracture sites were observed in 11 limbs. As a result, bone union was confirmed in 13 limbs. Five of the seven nonunion limbs required additional surgery. When comparing union and nonunion, open reduction and drilling were involved in nonunion limbs.
The surgical outcomes of atypical femoral fractures in patients with autoimmune disease and on long-term glucocorticoids and bisphosphonates were poor. Although it is not possible to affirm for sure based on these results alone, management with prophylactic surgery before complete fracture is considered to be required to improve outcomes.
糖皮质激素会诱发骨质疏松症,而双膦酸盐类药物用于治疗该疾病,但两者都可能导致非典型股骨骨折。由于其病理生理机制和药理作用,同时使用这两种药物的患者在这类骨折愈合方面可能面临挑战。
对19例患有非典型股骨骨折且患有自身免疫性疾病、因糖皮质激素诱发骨质疏松症而接受双膦酸盐治疗的患者的20条肢体进行了髓内钉手术。糖皮质激素和双膦酸盐的平均使用时长分别为17年和9年(标准差:7.59和4.35),平均随访期为66个月。分别有15条和5条肢体在转子下和骨干处骨折。检查了这些病例所采用的手术技术(髓内钉类型)及额外进行的手术操作。通过检查X线片上的术后对线和复位情况来确定它们与术后结果的关系。
9条肢体插入了头髓型长钉,11条肢体插入了顺行髓内钉。作为额外的手术操作,分别有6条、2条和5条肢体进行了切开复位、植骨和钻孔。关于X线片上的对线不良,前后位(AP)图像显示4条肢体有内翻,侧位图像显示2条肢体有伸展。关于皮质连续性,第11条肢体的远端骨折块在侧位视图中向后移位。11条肢体的骨折部位存在间隙。结果,13条肢体确认骨愈合。7条未愈合肢体中有5条需要再次手术。在比较愈合和未愈合情况时,未愈合肢体涉及切开复位和钻孔。
患有自身免疫性疾病且长期使用糖皮质激素和双膦酸盐的患者发生非典型股骨骨折的手术效果较差。尽管仅凭这些结果无法确切肯定,但为改善结果,考虑在完全骨折前进行预防性手术治疗。